BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 30728823)

  • 1. Germinal Center Alloantibody Responses Mediate Progression of Chronic Allograft Injury.
    Chhabra M; Alsughayyir J; Qureshi MS; Mallik M; Ali JM; Gamper I; Moseley EL; Peacock S; Kosmoliaptsis V; Goddard MJ; Linterman MA; Motallebzadeh R; Pettigrew GJ
    Front Immunol; 2018; 9():3038. PubMed ID: 30728823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative Frequencies of Alloantigen-Specific Helper CD4 T Cells and B Cells Determine Mode of Antibody-Mediated Allograft Rejection.
    Alsughayyir J; Chhabra M; Qureshi MS; Mallik M; Ali JM; Gamper I; Moseley EL; Peacock S; Kosmoliaptsis V; Goddard MJ; Linterman MA; Motallebzadeh R; Pettigrew GJ
    Front Immunol; 2018; 9():3039. PubMed ID: 30740108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germinal center humoral autoimmunity independently mediates progression of allograft vasculopathy.
    Qureshi MS; Alsughayyir J; Chhabra M; Ali JM; Goddard MJ; Devine CA; Conlon TM; Linterman MA; Motallebzadeh R; Pettigrew GJ
    J Autoimmun; 2019 Mar; 98():44-58. PubMed ID: 30528910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germinal center alloantibody responses are mediated exclusively by indirect-pathway CD4 T follicular helper cells.
    Conlon TM; Saeb-Parsy K; Cole JL; Motallebzadeh R; Qureshi MS; Rehakova S; Negus MC; Callaghan CJ; Bolton EM; Bradley JA; Pettigrew GJ
    J Immunol; 2012 Mar; 188(6):2643-52. PubMed ID: 22323543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathways of helper CD4 T cell allorecognition in generating alloantibody and CD8 T cell alloimmunity.
    Taylor AL; Negus SL; Negus M; Bolton EM; Bradley JA; Pettigrew GJ
    Transplantation; 2007 Apr; 83(7):931-7. PubMed ID: 17460565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell Allorecognition Pathways in Solid Organ Transplantation.
    Siu JHY; Surendrakumar V; Richards JA; Pettigrew GJ
    Front Immunol; 2018; 9():2548. PubMed ID: 30455697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed Cytotoxic T Lymphocyte-Associated Protein 4-Immunoglobulin Treatment Reverses Ongoing Alloantibody Responses and Rescues Allografts From Acute Rejection.
    Young JS; Chen J; Miller ML; Vu V; Tian C; Moon JJ; Alegre ML; Sciammas R; Chong AS
    Am J Transplant; 2016 Aug; 16(8):2312-23. PubMed ID: 26928966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abrogation of antibody-mediated allograft rejection by regulatory CD4 T cells with indirect allospecificity.
    Callaghan CJ; Rouhani FJ; Negus MC; Curry AJ; Bolton EM; Bradley JA; Pettigrew GJ
    J Immunol; 2007 Feb; 178(4):2221-8. PubMed ID: 17277127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissociation of mouse cardiac transplant rejection and donor alloantigen-specific T cell responsiveness.
    Bishop DK; DeBruyne LA; Chan S; Xu S; Eichwald EJ
    Transpl Immunol; 1995 Sep; 3(3):222-8. PubMed ID: 8581410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory CD8 T cells that recognize Qa-1 expressed by CD4 T-helper cells inhibit rejection of heart allografts.
    Choi JY; Eskandari SK; Cai S; Sulkaj I; Assaker JP; Allos H; AlHaddad J; Muhsin SA; Alhussain E; Mansouri A; Yeung MY; Seelen MAJ; Kim HJ; Cantor H; Azzi JR
    Proc Natl Acad Sci U S A; 2020 Mar; 117(11):6042-6046. PubMed ID: 32111690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of recipient CCR5 promotes early and increased allospecific antibody responses to cardiac allografts.
    Amano H; Bickerstaff A; Orosz CG; Novick AC; Toma H; Fairchild RL
    J Immunol; 2005 May; 174(10):6499-508. PubMed ID: 15879153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-Suppressor CXCR5+CD8+ T Cells Are More Potent Regulators of Humoral Alloimmunity after Kidney Transplant in Mice Compared to CD4+ Regulatory T Cells.
    Han JL; Zimmerer JM; Zeng Q; Chaudhari S; Satoskar A; Abdel-Rasoul M; Uwase H; Breuer CK; Bumgardner GL
    J Immunol; 2024 May; 212(9):1504-1518. PubMed ID: 38517294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of allograft survival by inhibitory FcγRIIb signaling.
    Callaghan CJ; Win TS; Motallebzadeh R; Conlon TM; Chhabra M; Harper I; Sivaganesh S; Bolton EM; Bradley JA; Brownlie RJ; Smith KG; Pettigrew GJ
    J Immunol; 2012 Dec; 189(12):5694-702. PubMed ID: 23150718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD40-independent help by memory CD4 T cells induces pathogenic alloantibody but does not lead to long-lasting humoral immunity.
    Rabant M; Gorbacheva V; Fan R; Yu H; Valujskikh A
    Am J Transplant; 2013 Nov; 13(11):2831-2841. PubMed ID: 24102790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of allograft ICAM-1 attenuates alloantigen-specific T cell priming, but not primed T cell trafficking into the graft, to mediate acute rejection.
    Zhang QW; Kish DD; Fairchild RL
    J Immunol; 2003 Jun; 170(11):5530-7. PubMed ID: 12759430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Passive transfer of alloantibodies restores acute cardiac rejection in IgKO mice.
    Wasowska BA; Qian Z; Cangello DL; Behrens E; Van Tran K; Layton J; Sanfilippo F; Baldwin WM
    Transplantation; 2001 Mar; 71(6):727-36. PubMed ID: 11330533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of Tfh:B Cell Interactions Prevents Antibody-Mediated Rejection in a Kidney Transplant Model in Rats: Impact of Calcineurin Inhibitor Dose.
    Steines L; Poth H; Schuster A; Amann K; Banas B; Bergler T
    Front Immunol; 2021; 12():657894. PubMed ID: 34135891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of allosensitization in allograft recipients: long-term cardiac allograft acceptance is associated with active alloantibody production in conjunction with active inhibition of alloreactive delayed-type hypersensitivity.
    VanBuskirk AM; Wakely ME; Sirak JH; Orosz CG
    Transplantation; 1998 Apr; 65(8):1115-23. PubMed ID: 9583874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blocking lymphotoxin signaling abrogates the development of ectopic lymphoid tissue within cardiac allografts and inhibits effector antibody responses.
    Motallebzadeh R; Rehakova S; Conlon TM; Win TS; Callaghan CJ; Goddard M; Bolton EM; Ruddle NH; Bradley JA; Pettigrew GJ
    FASEB J; 2012 Jan; 26(1):51-62. PubMed ID: 21926237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recipient natural killer cell allorecognition of passenger donor lymphocytes and its effect on adaptive alloimmunity after transplantation.
    Ali J; Harper I; Bolton E; Bradley JA; Pettigrew G
    Lancet; 2015 Feb; 385 Suppl 1():S18. PubMed ID: 26312840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.